Trials / Terminated
TerminatedNCT04452630
Cardiovascular Consequences After COVID-19
The CardioPostCovid Study: Cardiovascular Consequences After COVID-19
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coronavirus. The lack of characterization of cardiovascular damages linked to Covid-19 could have medium and long-term consequences on the prognosis of patients. This problematic could lead to a second major public health problem linked to Covid-19 and it is therefore crucial to keep monitoring and screening patients at risk. In this context of emerging infectious diseases, of poorly characterized cardiovascular damages during infection and of absence of data on the long-term evolution of the infection, the investigators propose to carry out a prospective and observational cohort study focused on the evaluation and the systematic cardiovascular follow up of patients who survived an episode of Covid-19, regardless of their cardiovascular profiles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Infectious Disease and Cardiology Clinical Consultations | Infectious Diseases and Cardiology Clinical Consultations at 1 month and 12 months of recovery from an episode of Covid-19 |
Timeline
- Start date
- 2020-06-23
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
- First posted
- 2020-06-30
- Last updated
- 2025-11-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04452630. Inclusion in this directory is not an endorsement.